PT94326A - Processo para a preparacao de polipeptidios e seus analogos e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de polipeptidios e seus analogos e de composicoes farmaceuticas que os contem

Info

Publication number
PT94326A
PT94326A PT94326A PT9432690A PT94326A PT 94326 A PT94326 A PT 94326A PT 94326 A PT94326 A PT 94326A PT 9432690 A PT9432690 A PT 9432690A PT 94326 A PT94326 A PT 94326A
Authority
PT
Portugal
Prior art keywords
pro
cys
lys
gly
ile
Prior art date
Application number
PT94326A
Other languages
English (en)
Other versions
PT94326B (pt
Inventor
Enno Christophers
Oliver Wiedow
Jens-Michael Schroder
Michael Derek Edg
David Pioli
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898913346A external-priority patent/GB8913346D0/en
Priority claimed from GB898913349A external-priority patent/GB8913349D0/en
Priority claimed from GB898921613A external-priority patent/GB8921613D0/en
Priority claimed from GB898924717A external-priority patent/GB8924717D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of PT94326A publication Critical patent/PT94326A/pt
Publication of PT94326B publication Critical patent/PT94326B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT94326A 1989-06-09 1990-06-08 Processo para a preparacao de polipeptidios e seus analogos e de composicoes farmaceuticas que os contem PT94326B (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898913346A GB8913346D0 (en) 1989-06-09 1989-06-09 Polypeptide analogues
GB898913349A GB8913349D0 (en) 1989-06-09 1989-06-09 Polypeptides
GB898921613A GB8921613D0 (en) 1989-09-25 1989-09-25 Polypeptides-1st update
GB898924717A GB8924717D0 (en) 1989-11-02 1989-11-02 Polypeptides

Publications (2)

Publication Number Publication Date
PT94326A true PT94326A (pt) 1991-02-08
PT94326B PT94326B (pt) 1997-01-31

Family

ID=27450350

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94326A PT94326B (pt) 1989-06-09 1990-06-08 Processo para a preparacao de polipeptidios e seus analogos e de composicoes farmaceuticas que os contem

Country Status (16)

Country Link
US (4) US5464822A (pt)
EP (1) EP0402068B1 (pt)
JP (1) JP2989853B2 (pt)
AT (1) ATE131493T1 (pt)
AU (1) AU636148B2 (pt)
CA (1) CA2018592C (pt)
DE (1) DE69024104T2 (pt)
DK (1) DK0402068T3 (pt)
ES (1) ES2080800T3 (pt)
FI (1) FI106471B (pt)
GR (1) GR3018401T3 (pt)
IE (1) IE70520B1 (pt)
IL (1) IL94602A (pt)
NO (1) NO177716C (pt)
NZ (1) NZ233974A (pt)
PT (1) PT94326B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
IE911698A1 (en) * 1990-05-24 1991-12-04 Ici Plc Therapeutic compound
EP0458536B1 (en) * 1990-05-24 1998-03-18 Zeneca Limited Therapeutic agent for treatment and prevention of adult respiratory distress syndrome
US5734014A (en) * 1992-08-11 1998-03-31 Tsumura & Co. Elafin derivative
US8606851B2 (en) 1995-06-06 2013-12-10 Wayport, Inc. Method and apparatus for geographic-based communications service
US5835061A (en) 1995-06-06 1998-11-10 Wayport, Inc. Method and apparatus for geographic-based communications service
EP0834556A1 (en) * 1996-09-25 1998-04-08 Academisch Ziekenhuis Leiden Methods for culturing cells
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001064031A2 (en) * 2000-03-01 2001-09-07 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Slpi knockout mice and methods for wound treatment
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
WO2003064605A2 (en) 2002-01-28 2003-08-07 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
MXPA04010560A (es) * 2002-04-25 2005-08-15 Scripps Research Inst Tratamiento y prevencion de condiciones pulmonares.
FR2849375B1 (fr) * 2002-12-30 2006-10-20 Jean Noel Thorel Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
EP1620121A2 (en) * 2003-05-07 2006-02-01 VIB vzw The use of a polypeptide domain of slpi to modulate the tumorigenic and metastatic potential of cancer cells
WO2006122404A1 (en) * 2005-05-16 2006-11-23 Her Majesty The Queen In Right As Represented By The Minister Of Health Trappin-2 (elafin) inhibits hiv
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
WO2010071833A1 (en) 2008-12-19 2010-06-24 Life Technologies Corporation Proteinase k inhibitors, methods and compositions therefor
GB201003559D0 (en) * 2010-03-03 2010-04-21 Proteo Biotech Ag Novel use of elafin
US20230285523A1 (en) * 2021-12-20 2023-09-14 Tiakis Biotech Ag Use of elafin in the treatment of covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
ATE162931T1 (de) * 1989-02-23 1998-02-15 Blood Res Center Menschlicher elastase-inhibitor
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff

Also Published As

Publication number Publication date
CA2018592A1 (en) 1990-12-09
GR3018401T3 (en) 1996-03-31
US20060068480A1 (en) 2006-03-30
PT94326B (pt) 1997-01-31
US5464822A (en) 1995-11-07
ES2080800T3 (es) 1996-02-16
DE69024104T2 (de) 1996-06-13
NO177716B (no) 1995-07-31
DK0402068T3 (da) 1996-04-22
CA2018592C (en) 2002-08-27
EP0402068A1 (en) 1990-12-12
ATE131493T1 (de) 1995-12-15
US6893843B2 (en) 2005-05-17
EP0402068B1 (en) 1995-12-13
AU5680890A (en) 1990-12-13
JPH03148299A (ja) 1991-06-25
US6245739B1 (en) 2001-06-12
IL94602A (en) 1996-06-18
FI902880A0 (fi) 1990-06-08
JP2989853B2 (ja) 1999-12-13
DE69024104D1 (de) 1996-01-25
IL94602A0 (en) 1991-04-15
FI106471B (fi) 2001-02-15
IE902006L (en) 1990-12-09
NO177716C (no) 1995-11-08
NZ233974A (en) 1993-05-26
NO902444D0 (no) 1990-06-01
US20020187535A1 (en) 2002-12-12
NO902444L (no) 1990-12-10
IE70520B1 (en) 1996-12-11
AU636148B2 (en) 1993-04-22

Similar Documents

Publication Publication Date Title
FI902880A0 (fi) Polypeptider och polypeptidanaloger.
PT97638A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ATE91233T1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
BR9905751A (pt) Compostos de dipeptìdeo, uso e processo para preparação dos mesmos, composições fungicidas, e, processos para a preparação das mesmas, e, para combater infecções por fungos
BR9102438A (pt) Derivados de azolil-propanol, processo para sua preparacao, composicoes fungicidas, emprego, processos para combater fungos e para a preparacao de composicoes, oxiranas e processo para sua preparacao
AR244492A1 (es) Composicion fungicida mejorada para el tratamiento de la madera.
CA2020663A1 (en) Substitution analogues of magainin peptides
BR9005785A (pt) Composicao fungicida,processo para combater fungos e processo para a preparacao de um composto fungicida
BR8701263A (pt) Processo para a preparacao de derivados de 5-acilamino-pirazol,composicoes herbicidas,processos para combater ervas daninhas e para a preparacao de composicoes
BR8402707A (pt) Composto,processo para sua preparacao,composicao fungicida,processo para controle de fungos patogenicos de plantas e uso do dito composto
BR8907521A (pt) Amino-cetais,processo para a sua preparacao,composicao fungicida e processos para combater fungos e para preparar uma composicao fungicida
IT1229522B (it) Procedimento per la preparazione di acido n fosfonometiliminodiacetico.
BR8702379A (pt) Composicao fungicida,processo para produzir uma composicao fungicida,composto de benzotiazinona,processo para a preparacao de um composto de benzotiazinona e processo para combater fungos num local
BR8605180A (pt) Composto derivado de(delta elevado ao quadrado)-1,2,4-triazolin-5-ona,processo para sua preparacao,composicao herbicida e processo para usar os referidos compostos como herbicidas
EP0339878A3 (en) Propanamine derivatives
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
BR8704961A (pt) Processo para a preparacao do composto,composicoes praguicidas,processos para a preparacao de uma composicao e para combater ou proteger de uma infestacao de plantas
IT8219650A0 (it) Derivati dagli acidi alfa o beta mercaptopropionilammidoacetici, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
BR8904339A (pt) Composicao fungicida,composto,composicao fungicida,processo para combater fungos,uso,como fungicida,de uma composicao e processo para a preparacao do composto
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
DK568584D0 (da) Azabicyclo(3,3,1)nonan-9-oner eller stereoisomere eller farmaceutiskacceptable syreadditionssalte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen
BR9000865A (pt) Aziniliminoheteroazois sulfonilados,processo para sua preparacao,composicoes herbicidas,processos para combater ervas daninhas e para a preparacao de composicoes e aziniliminoheteroazois
BR8601314A (pt) Compostos herbicidas,processo para sua preparacao,composicao herbicida e processo para combater o crescimento de uma planta indesejada
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
BR8601948A (pt) Processo para a preparacao de um composto e de uma composicao para combater as infeccoes ou infestacoes e processo para combater as infeccoes ou infestacoes

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961011

PC3A Transfer or assignment

Free format text: 20001004 OLIVER WIEDOW, DR. DE

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20111011